The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors

Blood

Volumn 94, Issue 7, 1999, Pages 2343-2356

  Bühring, Hans Jörg ^a   Simmons, Paul J ^b   Pudney, Melanie ^b   Müller, Robert ^b   Jarrossay, David ^b   Van Agthoven, Andreas ^b   Willheim, Martin ^b   Brugger, Wolfram ^b   Valent, Peter ^b   Kanz, Lothar ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MONOCLONAL ANTIBODY; STEM CELL FACTOR;

ANTIGEN EXPRESSION; ARTICLE; BASOPHIL; CELL LINEAGE; CELL SPECIFICITY; CELLULAR DISTRIBUTION; EOSINOPHIL; HUMAN; HUMAN CELL; MACROPHAGE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; STEM CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; ANTIGENS, CD34; BASOPHILS; BONE MARROW CELLS; CELL LINE; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CYTOKINES; HEMATOPOIETIC STEM CELLS; HISTAMINE RELEASE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LUNG; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SKIN;

EID: 0345672741     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Schwartz LB: The mast cell, in Kaplan AP (ed): Allergy, vol 1. Edinburgh, Scotland, Churchill Livingstone, 1985, p 53
2. Galli SJ: Biology of disease: New insights into "the riddle of mast cells": Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62:5, 1990
3. Valent P, Bettelheim P: The human basophil. Crit Rev Oncol Hematol 10:327, 1990
4. Johnston SL, Holgate ST: Cellular and chemical mediators -Their roles in allergic diseases. Curr Opin Immunol 2:513, 1990
5. Serafin WE, Austen KF: Mediators of immediate hypersensitivity reactions. N Engl J Med 317:30, 1987
6. Ishizaka T, Ishizaka K: Activation of mast cells for mediator release through IgE receptors. Prog Allergy 34:188, 1984
7. Dvorak AM, Lett-Brown M, Thueson D, Grant JA: Complement-induced degranulation of human basophils. J Immunol 126:532, 1981
8. Valent P, Bettelheim P: Cell surface structures on human basophils and mast cells: Biochemical and functional characterization. Adv Immunol 52:333, 1992
9. Peachell PT, Lichtenstein LM, Schleimer RP: Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther 256:717, 1991
10. Füreder W, Agis H, Semper H, Keil F, Maier U, Czerwenka K, Müller MR, Höfler H, Lechner K, Valent P: Differential response of human basophils and mast cells to recombinant human chemokines. Ann Hematol 70:251, 1995
11. Valent P, Besemer J, Muhm M, Majdic O, Lechner K, Bettelheim P: Interleukin-3 activates human basophils via high affinity binding sites. Proc Natl Acad Sci USA 86:5542, 1989
12. Valent P: The riddle of the mast cell: c-kit ligand as the missing link? Immunol Today 15:111, 1994
13. Valent P, Besemer J, Sillaber CH, Maurer D, Butterfield JH, Kishi K, Lechner K, Bettelheim P: Failure to detect interleukin-3 binding sites on human mast cells. J Immunol 145:3432, 1990
14. Valent P: The phenotype of human eosinophils, basophils, and mast cells. J Allergy Clin Immunol 94:1177, 1994
15. + pluripotent progenitor cells. J Immunol 148:772, 1992
16. - colony-forming cell. J Immunol 151:4221, 1993
17. Födinger M, Fritsch G, Winkler K, Emminger W, Mitterbauer G, Gadner H, Valent P, Mannhalter C: Origin of human mast cells: Development from transplanted hemopoietic stem cells after allogeneic bone marrow transplantation. Blood 84:2954, 1994
18. Saito H, Ebisawa M, Tachimoto H, Shichijo M, Fukagawa K, Matsumoto K, Iikura Y, Awaji T, Tsujimoto G, Yanagida M, Uzumaki H, Takahashi G, Tsuji K, Nakahata T: Selective growth of human mast cells induced by steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 157:343, 1996
19. Valent P, Schmidt G, Besemer J, Mayer P, Liehl E, Hinterberger W, Lechner K, Maurer D, Bettelheim P: Interleukin-3 is a differentiation factor for human basophils. Blood 73:1763, 1989
20. Leary AG, Ogawa M: Identification of pure and mixed basophil colonies in culture of human peripheral blood and marrow cells. Blood 64:78, 1984
21. Denburg JA, Silver JE, Abrams JS: Interleukin-5 is a human basophilopoietin: Induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors. Blood 77:1462, 1991
22. Irani AM, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, Zsebo KM, Schwartz LB: Recombinant human stem cell factor stimulates differentiation of human mast cells from dispersed fetal liver cells. Blood 80:3009, 1992
23. Mitsui H, Furitsu T, Dvorak AM, Irani AMA, Schwartz LB, Inagaki N, Takei M, Ishizaka K, Zsebo KM, Gillis S, Ishizaka T: Development of human mast cells from umbilical cord blood cells by recombinant human and murine stem cell factor, c-kit ligand. Proc Natl Acad Sci USA 90:735, 1993
24. Valent P, Spanblöchl E, Sperr WR, Sillaber CH, Agis H, Zsebo K, Geissler K, Bettelheim P, Lechner K: Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (SCF)/kit ligand (KL) in long term culture. Blood 80:2237, 1992
25. Xia HZ, Du Z, Craig S, Klisch G, Noben-Trauth N, Kochan JP, Huff TH, Irani AM, Schwartz LB: Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J Immunol 159:2911, 1997
26. Yanagida M, Fukamachi H, Ohgami K, Kuwaki T, Ishii H, Uzumaki H, Amano K, Tokiwa T, Mitsui H, Saito H, Iikura Y, Ishizaka T, Nakahata T: Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86:3705, 1995
27. Agis H, Füreder W, Bankl HC, Kundi M, Sperr WR, Willheim M, Boltz-Nitulescu G, Butterfield JH, Kishi K, Lechner K, Valent P: Comparative phenotypic analysis of human mast cells, blood monocytes and blood basophils: Dissection of three distinct myeloid cell lineages. Immunology 87:535, 1996
28. Bodger MP, Mounsey GL, Nelson J, Fitzgerald PH: A monoclonal antibody reacting with human basophils. Blood 69:1414, 1987
29. Valent P, Majdic O, Maurer D, Bodger M, Muhm M, Bettelheim P: Further characterization of surface membrane structures expressed on human basophils and mast cells. Int Arch Allergy Appl Immunol 91:198, 1990
30. Kepley CL, Craig SS, Schwartz LB: Identification and partial characterization of a unique marker for human basophils. J Immunol 154:6548, 1995
31. Mayrhofer G, Gadd SJ, Spargo LD, Ashman LK: Specificity of a mouse monoclonal antibody raised against acute myeloid leukemia cells, for mast cells in mucosal and connective tissues. Immunol Cell Biol 65:241, 1987
32. Lerner NB, Nocka KH, Cole SR, Qiu FH, Strife A, Ashman LK, Besmer P: Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 77:1876, 1991
33. Ashman LK, Cambareri AC, To LB, Levinski RJ, Juttner CA: Expression of c-kit antigen (c-kit proto-oncogen product) by normal human bone marrow cells. Blood 78:30, 1991
34. Komatsu N, Nakauichi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y, Suda T, Miura Y: Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocyte-macrophage colony stimulating factor, interleukin-3, or erythropoietin for growth and survival. Cancer Res 51:341, 1991
35. Rappold I, Ziegler BL, Köhler I, Marchetto, S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino ACW, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Bühring HJ: Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 receptor tyrosine kinase. Blood 90:111, 1997
36. Oi VT, Glazer AN, Stryer L: Fluorescent phycobiliprotein conjugates for analyses of cells and molecules. J Cell Biol 93:981, 1982
37. Schulman ES, MacGlashan DW, Peters SP, Schleimer RP, Newball HH, Lichtenstein LM: Human lung mast cells: Purification and characterization. J Immunol 129:2662, 1982
38. Valent P, Ashman LK, Hinterberger W, Eckersberger F, Majdic O, Lechner K, Maurer D, Bettelheim P: Mast cell typing: Demonstration of a distinct hemopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 73:1778, 1989
39. Massey WA, Guo CB, Dvorak AM, Hrubbard WC, Bhagavan BS, Cohan VL, Warner JA, Sobotka AK, Lichtenstein LM: Human uterine mast cells: Isolation, purification, characterization, ultrastructure, and pharmacology. J Immunol 147:1621, 1991
40. Füreder W, Agis H, Willheim M, Bankl HC, Maier U, Kishi K, Müller M, Czerwenka K, Radaszkiewicz T, Butterfield JH, Klappacher GW, Sperr WR, Oppermann M, Lechner K, Valent P: Differential expression of complement receptors on human mast cells and basophils: Evidence for mast cell heterogeneity and C5aR/CD88 expression on skin mast cells. J Immunol 155:3152, 1995
41. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345, 1988
42. Kishi K: A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 9:381, 1985
43. Saito H, Bourinbaiar A, Ginsburg M, Minato K, Ceresi E, Yamada K, Machover D, Breard J, Mathe G: Establishment and characterization of a new human eosinophilic leukemia cell line. Blood 66:1233, 1985
44. Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, Saito H: Establishment of a novel human megakaryoblastic leukemia line, MEG-O1, with positive Philadelphia chromosome. Blood 66: 1384, 1985
45. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, II-3, or erythropoietin. J Cell Physiol 140:323, 1989
46. Matsuo Y, Adachi T, Tsubota T, Imanishi J, Minowada J: Establishment and characterization of a novel megakaryoblastoid cell line, MOLM-1, from a patient with chronic myelogenous leukemia. Hum Cell 4:261, 1991
47. Koistinen P, Wang C, Yang GS, Wang Y-F, Williams DE, Lyman SD, Minden MD, McCulloch EA: OC1/AML-4, an acute myeloblastic leukemia cell line: Regulation and response to cytosine arabinoside. Leukemia 5:704, 1991
48. Guerriero R, Testa U, Gabbianelli M, Mattia G, Montesoro E, Macioce G, Pace A, Ziegler B, Hassan HJ, Peschle C: Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood 86:3725, 1995
49. Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwaan JK, Van der Linden PW: Development of a new, more sensitive assay for human tryptase: Use in systemic anaphylaxis. J Clin Immunol 14:190, 1994
50. Wimazal F, Walchshofer S, Baghestanian M, Chott A, Sperr WR, Kopp C, Sillaber C, Semper H, Horny HP, Tröndle U, Födinger M, Schwarzinger I, Lechner K, Valent P: Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis. Wien Klin Wochenschr 110:79, 1998
51. Stain C, Stockinger H, Scharf M, Jäger U, Gössinger H, Lechner K, Bettelheim P: Human blood basophils display a unique phenotype including activation-linked membrane structures. Blood 70:1872, 1987
52. Watt SM, Bühring HJ, Chan YS, Lee-Prudhoe J, Rappold I, Jones T, Benton MA, Zannettino ACW, Simmons PJ, Sheer D, Butler L: CD164 a mucin-like inhibitory receptor on CD34+ and erythroid cell subsets is located on human chromosome 6q21. Blood 92:849, 1998
53. Zannettino ACW, Bühring HJ, Watt SM, Benton AM, Niutta S, Simmons PJ: Identification and functional cloning of CD164 (MGC-24v): A novel mucin-like adhesion molecule expressed by hematopoietic progenitor and bone marrow stromal cells. Blood 92: 2613, 1998
54. Sperr WR, Agis H, Cerwenka K, Kubista E, Boltz-Nitulescu G, Eckersberger F, Klepetko W, Lechner K, Valent P: Differential expression of cell surface integrins on human mast cells and basophils. Ann Hematol 65:10, 1992
55. Agis H, Füreder W, Bankl HC, Kundi M, Sperr WR, Willheim M, Boltz-Nitulescu G, Butterfield JH, Kishi K, Lechner K, Valent P: Comparative phenotypic analysis of human mast cells, blood monocytes and blood basophils: Dissection of three distinct myeloid cell lineages. Immunology 87:353, 1996
56. Füreder W, Agis H, Sperr WR, Lechner K, Valent P: The surface membrane antigen phenotype of human blood basophils. Allergy 49:861, 1994
57. Bühring HJ, Herbst R, Kostka G, Bossenmaier B, Bartke I, Kropshofer H, Kalbacher H, Busch FW, Müller CA, Schlessinger J, Ullrich A: Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia. Cancer Res 53:4424, 1993
58. Fornelli CS, George F, Sampol J, van Agthoven AJ: Biochemical analysis of endothelial antigens recognized by Workshop mAb, in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds): Leucocyte Typing V. Oxford, UK, Oxford University Press, 1995, p 1791
59. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
60. Tedder TF, Wagner N, Engel P: CD81 Workshop report, in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds): Leucocyte Typing V. Oxford, UK, Oxford University Press, 1995, p 684
61. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M: Chronic myelogenous leukemia: A concise update. Blood 82:691, 1993